
Two Kidney Week 2026 abstracts show a dose-response link between cardiovascular-kidney-metabolic syndrome (CKM) stage and chronic kidney disease (CKD), while primary care clinicians cite evidence and workflow barriers.
Pharmacy Times spoke with Josh Benner, pharmacist and CEO/founder of RxAnte, about medication misuse and the future of pharmacy in 2021.
Pharmacy Times spoke with Josh Benner, pharmacist and CEO/founder of RxAnte, about medication misuse and the future of pharmacy in 2021.
With 25 years in the industry previous to COVID-19, Benner used the example of his own technology and clinical services company to describe how he has seen 2 segments of the population during the pandemic and their handling of medication misuse.
Benner also discussed barriers to medication adherence, how the role of the pharmacist has changed, and the future of pharmacy in 2021.






